France - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, France Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale fell by 2.6% year on year. At €642,378,032.96 in 2019, the country was ranked number 5 comparing other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. France is overtaken by Germany, which was ranked number 4 at €718,679,434.78 and is followed by Spain at €176,754,726.66. Denmark topped the ranking with €3,801,340,964.3 in 2019, a decrease of 2.9% compared to 2018. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 642,378,032.96
2018 625,470,227.00
2017 861,518,926.00
2016 819,403,528.00
2015 942,169,940.00
Download all data from 1995 to 2019

How does France rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
4 #4
Germany
718,679,434.78 2019 -1.4 % -4.9 % View data
5 #5
France
642,378,032.96 2019 +2.7 % -2.6 % View data
6 #6
Spain
176,754,726.66 2019 +0.2 % +7.5 % View data
Compare all 16 countries

Go Top